About
Sepsis diagnosis
Areas of Focus
Categories
DiagnosticsSeattle/Pacific Northwest
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
3
As Collaborator
3
Total Enrollment
8,212
By Status
COMPLETED: 4TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05469048Lead Sponsor
Near Patient Molecular Testing in Sepsis
N/ACompleted
63 participants
Started: Mar 12, 2020 · Completed: Oct 31, 2022
NCT06231862Collaborator
Gene Expression Objective Definition of Early Sepsis In Children
N/ACompleted
100 participants
Started: Mar 1, 2019 · Completed: Mar 1, 2023
NCT02704871Lead Sponsor
The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS
N/ATerminated
66 participants
Started: Jun 30, 2015 · Completed: Feb 28, 2018
NCT02127502Lead Sponsor
VENUS: Septic Gene Expression Using SeptiCyte
N/ACompleted
379 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2016
NCT02728401Collaborator
Genotypes and Phenotypes in Pediatric SIRS and Sepsis
N/ACompleted
104 participants
Started: May 1, 2013 · Completed: Dec 31, 2017
Locations (1)
Headquarters
Seattle, WA, United States
Map
Loading map...